{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:57:48Z","timestamp":1792799868465,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41591-025-03565-2","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:40:19Z","timestamp":1744270819000},"page":"1592-1603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8192-7593","authenticated-orcid":false,"given":"Hamilton Se-Hwee","family":"Oh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz Yagmur","family":"Urey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0630-772X","authenticated-orcid":false,"given":"Linda","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Farinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigyasha","family":"Timsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1029-4423","authenticated-orcid":false,"given":"Michael R.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Guldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-9651","authenticated-orcid":false,"given":"Nader","family":"Morshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4577-5590","authenticated-orcid":false,"given":"Chengran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-9553","authenticated-orcid":false,"given":"Daniel","family":"Western","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6631","authenticated-orcid":false,"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6649-8364","authenticated-orcid":false,"given":"Yann","family":"Le Guen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Trelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna-Kaisa","family":"Herukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Rauramaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Hiltunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4403-9084","authenticated-orcid":false,"given":"Anssi","family":"Lipponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti J.","family":"Luikku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-7143","authenticated-orcid":false,"given":"Kathleen L.","family":"Poston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Mormino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0624-4543","authenticated-orcid":false,"given":"Anthony D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-5247","authenticated-orcid":false,"given":"Edward N.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Channappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Ehrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-1256","authenticated-orcid":false,"given":"Rebecca F.","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-0669","authenticated-orcid":false,"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5989-9853","authenticated-orcid":false,"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9736-2283","authenticated-orcid":false,"given":"Nicolai","family":"Franzmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5893-0831","authenticated-orcid":false,"given":"Tony","family":"Wyss-Coray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"3565_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3565_CR2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41591-020-0938-9","volume":"26","author":"S Dujardin","year":"2020","unstructured":"Dujardin, S. et al. Tau molecular diversity contributes to clinical heterogeneity in Alzheimer\u2019s disease. Nat. Med. 26, 1256\u20131263 (2020).","journal-title":"Nat. Med."},{"key":"3565_CR3","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"3565_CR4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaneurol.2022.2379","volume":"79","author":"C Strikwerda-Brown","year":"2022","unstructured":"Strikwerda-Brown, C. et al. Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment. JAMA Neurol. 79, 975\u2013985 (2022).","journal-title":"JAMA Neurol."},{"key":"3565_CR5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41380-020-0721-9","volume":"26","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg, H. & Bendlin, B. B. Biomarkers for Alzheimer\u2019s disease\u2014preparing for a new era of disease-modifying therapies. Mol. Psychiatry. 26, 296\u2013308 (2021).","journal-title":"Mol. Psychiatry."},{"key":"3565_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"H van Dyck Christopher","year":"2023","unstructured":"van Dyck Christopher, H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"3565_CR7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954\u2013963 (2021).","journal-title":"Nat. Med."},{"key":"3565_CR8","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi, S. et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat. Neurosci. 21, 811\u2013819 (2018).","journal-title":"Nat. Neurosci."},{"key":"3565_CR9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw, B. J. et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. JAMA Neurol. 76, 915\u2013924 (2019).","journal-title":"JAMA Neurol."},{"key":"3565_CR10","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/brain\/awab092","volume":"144","author":"PA Boyle","year":"2021","unstructured":"Boyle, P. A. et al. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain 144, 2166\u20132175 (2021).","journal-title":"Brain"},{"key":"3565_CR11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/alz.12480","volume":"18","author":"D Tosun","year":"2022","unstructured":"Tosun, D. et al. Contribution of Alzheimer\u2019s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer\u2019s disease continuum. Alzheimers Dement. 18, 1370\u20131382 (2022).","journal-title":"Alzheimers Dement."},{"key":"3565_CR12","volume":"2","author":"SL Andersen","year":"2020","unstructured":"Andersen, S. L. Centenarians as models of resistance and resilience to Alzheimer\u2019s disease and related dementias. Adv. Geriatr. Med. Res. 2, e200018 (2020).","journal-title":"Adv. Geriatr. Med. Res."},{"key":"3565_CR13","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1002\/alz.13087","volume":"19","author":"M Zhang","year":"2023","unstructured":"Zhang, M. et al. The correlation between neuropathology levels and cognitive performance in centenarians. Alzheimers Dement. 19, 5036\u20135047 (2023).","journal-title":"Alzheimers Dement."},{"key":"3565_CR14","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"3565_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13195-023-01319-1","volume":"15","author":"F Mart\u00ednez-Dubarbie","year":"2023","unstructured":"Mart\u00ednez-Dubarbie, F. et al. Accuracy of plasma A\u03b240, A\u03b242, and p-tau181 to detect CSF Alzheimer\u2019s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform. Alzheimers Res. Ther. 15, 163 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"3565_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13195-023-01291-w","volume":"15","author":"C Motta","year":"2023","unstructured":"Motta, C. et al. Different associations between amyloid-\u03b2eta 42, amyloid-\u03b2eta 40, and amyloid-\u03b2eta 42\/40 with soluble phosphorylated-tau and disease burden in Alzheimer\u2019s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study. Alzheimers Res. Ther. 15, 144 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"3565_CR17","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","volume":"29","author":"K Horie","year":"2023","unstructured":"Horie, K. et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease. Nat. Med. 29, 1954\u20131963 (2023).","journal-title":"Nat. Med."},{"key":"3565_CR18","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamaneurol.2022.2967","volume":"79","author":"WM van der Flier","year":"2022","unstructured":"van der Flier, W. M. & Scheltens, P. The ATN Framework\u2014moving preclinical Alzheimer disease to clinical relevance. JAMA Neurol. 79, 968\u2013970 (2022).","journal-title":"JAMA Neurol."},{"key":"3565_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuron.2019.05.002","volume":"103","author":"F Koopmans","year":"2019","unstructured":"Koopmans, F. et al. SynGO: an evidence-based, expert-curated knowledge base for the synapse. Neuron 103, 217\u2013234 (2019).","journal-title":"Neuron"},{"key":"3565_CR20","unstructured":"Cruchaga, C. et al. Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum. Neuron (in the press)."},{"key":"3565_CR21","doi-asserted-by":"crossref","first-page":"eaap8734","DOI":"10.1126\/scisignal.aap8734","volume":"11","author":"NR Stallings","year":"2018","unstructured":"Stallings, N. R. et al. Pin1 mediates A\u03b242-induced dendritic spine loss. Sci. Signal. 11, eaap8734 (2018).","journal-title":"Sci. Signal."},{"key":"3565_CR22","doi-asserted-by":"crossref","first-page":"E3773","DOI":"10.1073\/pnas.1516867113","volume":"113","author":"Y Yin","year":"2016","unstructured":"Yin, Y. et al. Tau accumulation induces synaptic impairment and memory deficit by calcineurin-mediated inactivation of nuclear CaMKIV\/CREB signaling. Proc. Natl Acad. Sci. USA 113, E3773\u2013E3781 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3565_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13195-023-01323-5","volume":"15","author":"NR Stallings","year":"2023","unstructured":"Stallings, N. R., O\u2019Neal, M. A., Hu, J., Shen, Z.-J. & Malter, J. S. Long-term normalization of calcineurin activity in model mice rescues Pin1 and attenuates Alzheimer\u2019s phenotypes without blocking peripheral T cell IL-2 response. Alzheimers Res. Ther. 15, 179 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"3565_CR24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-022-01356-1","volume":"10","author":"E Drummond","year":"2022","unstructured":"Drummond, E. et al. The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome. Acta Neuropathol. Commun. 10, 53 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"3565_CR25","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson, E. C. B. et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat. Med. 29, 1979\u20131988 (2023).","journal-title":"Nat. Med."},{"key":"3565_CR26","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/nn.2621","volume":"13","author":"MC Chang","year":"2010","unstructured":"Chang, M. C. et al. Narp regulates homeostatic scaling of excitatory synapses on parvalbumin-expressing interneurons. Nat. Neurosci. 13, 1090\u20131097 (2010).","journal-title":"Nat. Neurosci."},{"key":"3565_CR27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.neuron.2015.02.020","volume":"85","author":"KA Pelkey","year":"2015","unstructured":"Pelkey, K. A. et al. Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons. Neuron 85, 1257\u20131272 (2015).","journal-title":"Neuron"},{"key":"3565_CR28","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","volume":"186","author":"H Mathys","year":"2023","unstructured":"Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186, 4365\u20134385 (2023).","journal-title":"Cell"},{"key":"3565_CR29","doi-asserted-by":"crossref","first-page":"100542","DOI":"10.1016\/j.mcpro.2023.100542","volume":"22","author":"C Hurst","year":"2023","unstructured":"Hurst, C. et al. Integrated proteomics to understand the role of neuritin (NRN1) as a mediator of cognitive resilience to Alzheimer\u2019s disease. Mol. Cell. Proteomics 22, 100542 (2023).","journal-title":"Mol. Cell. Proteomics"},{"key":"3565_CR30","doi-asserted-by":"crossref","first-page":"eadf0141","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou, J. et al. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci. Transl. Med. 15, eadf0141 (2023).","journal-title":"Sci. Transl. Med."},{"key":"3565_CR31","doi-asserted-by":"crossref","first-page":"1800105","DOI":"10.1002\/prca.201800105","volume":"13","author":"G Sathe","year":"2019","unstructured":"Sathe, G. et al. Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer\u2019s disease. Proteomics Clin. Appl. 13, 1800105 (2019).","journal-title":"Proteomics Clin. Appl."},{"key":"3565_CR32","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/brain\/awae032","volume":"147","author":"J Nilsson","year":"2024","unstructured":"Nilsson, J. et al. Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases. Brain 147, 2414\u20132427 (2024).","journal-title":"Brain"},{"key":"3565_CR33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-220399","volume":"89","author":"J Timsina","year":"2022","unstructured":"Timsina, J. et al. Comparative analysis of Alzheimer\u2019s disease cerebrospinal fluid biomarkers measurement by multiplex SOMAscan platform and immunoassay-based approach. J. Alzheimers Dis. 89, 193\u2013207 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"3565_CR34","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1212\/WNL.0000000000201417","volume":"100","author":"A \u00d6hrfelt","year":"2023","unstructured":"\u00d6hrfelt, A. et al. Association of CSF GAP-43 with the rate of cognitive decline and progression to dementia in amyloid-positive individuals. Neurology 100, e275\u2013e285 (2023).","journal-title":"Neurology"},{"key":"3565_CR35","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.cell.2024.08.049","volume":"187","author":"Y Shen","year":"2024","unstructured":"Shen, Y. et al. CSF proteomics identifies early changes in autosomal dominant Alzheimer\u2019s disease. Cell 187, 6309\u20136326 (2024).","journal-title":"Cell"},{"key":"3565_CR36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman, D. C. et al. Symptom onset in autosomal dominant Alzheimer disease. Neurology 83, 253\u2013260 (2014).","journal-title":"Neurology"},{"key":"3565_CR37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.2008.01326.x","volume":"119","author":"AJ Mitchell","year":"2009","unstructured":"Mitchell, A. J. & Shiri-Feshki, M. Rate of progression of mild cognitive impairment to dementia\u2014meta-analysis of 41 robust inception cohort studies. Acta Psychiatr. Scand. 119, 252\u2013265 (2009).","journal-title":"Acta Psychiatr. Scand."},{"key":"3565_CR38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"3565_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","volume":"3","author":"AM Pooler","year":"2015","unstructured":"Pooler, A. M. et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease. Acta Neuropathol. Commun. 3, 14 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"3565_CR40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092 (2016).","journal-title":"Nat. Neurosci."},{"key":"3565_CR41","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-44374-w","volume":"15","author":"N Franzmeier","year":"2024","unstructured":"Franzmeier, N. et al. Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer\u2019s disease. Nat. Commun. 15, 202 (2024).","journal-title":"Nat. Commun."},{"key":"3565_CR42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473\u2013489 (2021).","journal-title":"Nat. Aging"},{"key":"3565_CR43","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/s41593-024-01774-5","volume":"27","author":"MI Gabitto","year":"2024","unstructured":"Gabitto, M. I. et al. Integrated multimodal cell atlas of Alzheimer's disease. Nat. Neurosci. 27, 2366\u20132383 (2024).","journal-title":"Nat. Neurosci."},{"key":"3565_CR44","first-page":"8407609","volume":"2018","author":"J Zhang","year":"2018","unstructured":"Zhang, J. & Zhou, Y. 14-3-3 proteins in glutamatergic synapses. Neural Plast. 2018, 8407609 (2018).","journal-title":"Neural Plast."},{"key":"3565_CR45","doi-asserted-by":"crossref","first-page":"632466","DOI":"10.3389\/fgene.2021.632466","volume":"12","author":"X-G Ye","year":"2021","unstructured":"Ye, X.-G. et al. YWHAG mutations cause childhood myoclonic epilepsy and febrile seizures: molecular sub-regional effect and mechanism. Front. Genet. 12, 632466 (2021).","journal-title":"Front. Genet."},{"key":"3565_CR46","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.15574","volume":"288","author":"JF Neves","year":"2021","unstructured":"Neves, J. F. et al. Phosphorylated full-length Tau interacts with 14-3-3 proteins via two short phosphorylated sequences, each occupying a binding groove of 14-3-3 dimer. FEBS J. 288, 1918\u20131934 (2021).","journal-title":"FEBS J."},{"key":"3565_CR47","doi-asserted-by":"publisher","unstructured":"Hochmair, J. et al. 14-3-3 binding regulates Tau assembly and microtubule association. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.03.15.585148 (2024).","DOI":"10.1101\/2024.03.15.585148"},{"key":"3565_CR48","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","volume":"335","author":"G Hsich","year":"1996","unstructured":"Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H. & Harrington, M. G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N. Engl. J. Med. 335, 924\u2013930 (1996).","journal-title":"N. Engl. J. Med."},{"key":"3565_CR49","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105380","volume":"39","author":"N Scott\u2010Hewitt","year":"2020","unstructured":"Scott\u2010Hewitt, N. et al. Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. EMBO J. 39, e105380 (2020).","journal-title":"EMBO J."},{"key":"3565_CR50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","volume":"12","author":"M Colom-Cadena","year":"2020","unstructured":"Colom-Cadena, M. et al. The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alzheimers Res. Ther. 12, 21 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"3565_CR51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrn3200","volume":"13","author":"JH Morrison","year":"2012","unstructured":"Morrison, J. H. & Baxter, M. G. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat. Rev. Neurosci. 13, 240\u2013250 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"3565_CR52","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/alz.12809","volume":"19","author":"J Nilsson","year":"2023","unstructured":"Nilsson, J. et al. Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer\u2019s disease and other neurodegenerative disorders. Alzheimers Dement. 19, 1775\u20131784 (2023).","journal-title":"Alzheimers Dement."},{"key":"3565_CR53","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS Oh","year":"2023","unstructured":"Oh, H. S. et al. Organ aging signatures in the plasma proteome track health and disease. Nature 624, 164\u2013172 (2023).","journal-title":"Nature"},{"key":"3565_CR54","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13195-022-01116-2","volume":"14","author":"EN Wilson","year":"2022","unstructured":"Wilson, E. N. et al. Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 172 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"3565_CR55","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awaa021","volume":"143","author":"EN Wilson","year":"2020","unstructured":"Wilson, E. N. et al. Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau. Brain 143, 932\u2013943 (2020).","journal-title":"Brain"},{"key":"3565_CR56","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/acn3.52034","volume":"11","author":"MJ Plastini","year":"2024","unstructured":"Plastini, M. J. et al. Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer\u2019s disease spectra. Ann. Clin. Transl. Neurol. 11, 1197\u20131210 (2024).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"3565_CR57","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"3565_CR58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.JGP.0000192478.82189.a8","volume":"14","author":"R Perneczky","year":"2006","unstructured":"Perneczky, R. et al. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am. J. Geriatr. Psychiatry 14, 139\u2013144 (2006).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"3565_CR59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"3565_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34129-4","volume":"13","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette, A. et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat. Commun. 13, 6635 (2022).","journal-title":"Nat. Commun."},{"key":"3565_CR61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-150909","volume":"52","author":"AM Koivisto","year":"2016","unstructured":"Koivisto, A. M. et al. High risk of dementia in ventricular enlargement with normal pressure hydrocephalus related symptoms. J. Alzheimers Dis. 52, 497\u2013507 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"3565_CR62","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3233\/JAD-201363","volume":"81","author":"O Nerg","year":"2021","unstructured":"Nerg, O. et al. The CERAD neuropsychological battery in patients with idiopathic normal pressure hydrocephalus compared with normal population and patients with mild Alzheimer\u2019s disease. J. Alzheimers Dis. 81, 1117\u20131130 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"3565_CR63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12014-022-09354-0","volume":"19","author":"S Weiner","year":"2022","unstructured":"Weiner, S. et al. Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer\u2019s disease biomarkers. Clin. Proteomics 19, 13 (2022).","journal-title":"Clin. Proteomics"},{"key":"3565_CR64","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious Orders Study and Rush Memory and Aging Project. J. Alzheimers Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"3565_CR65","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A. et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66, 1837\u20131844 (2006).","journal-title":"Neurology"},{"key":"3565_CR66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett, D. A. et al. Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27, 169\u2013176 (2006).","journal-title":"Neuroepidemiology"},{"key":"3565_CR67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.59.2.198","volume":"59","author":"DA Bennett","year":"2002","unstructured":"Bennett, D. A. et al. Natural history of mild cognitive impairment in older persons. Neurology 59, 198\u2013205 (2002).","journal-title":"Neurology"},{"key":"3565_CR68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ana.25380","volume":"85","author":"PA Boyle","year":"2019","unstructured":"Boyle, P. A. et al. Attributable risk of Alzheimer\u2019s dementia attributed to age-related neuropathologies. Ann. Neurol. 85, 114\u2013124 (2019).","journal-title":"Ann. Neurol."},{"key":"3565_CR69","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1212\/WNL.0000000000206833","volume":"100","author":"S Oveisgharan","year":"2023","unstructured":"Oveisgharan, S. et al. Estrogen receptor genes, cognitive decline, and Alzheimer disease. Neurology 100, e1474\u2013e1487 (2023).","journal-title":"Neurology"},{"key":"3565_CR70","first-page":"2939","volume":"77","author":"JD Wright","year":"2021","unstructured":"Wright, J. D. et al. The ARIC (Atherosclerosis Risk In Communities) study: JACC focus seminar 3\/8. J. Am. Coll. Cardiol. 77, 2939\u20132959 (2021).","journal-title":"J."},{"key":"3565_CR71","first-page":"1","volume":"2","author":"DS Knopman","year":"2016","unstructured":"Knopman, D. S. et al. Mild cognitive impairment and dementia prevalence: the Atherosclerosis Risk in Communities neurocognitive study. Alzheimers Dement. 2, 1\u201311 (2016).","journal-title":"Alzheimers Dement."},{"key":"3565_CR72","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","volume":"25","author":"SA Williams","year":"2019","unstructured":"Williams, S. A. et al. Plasma protein patterns as comprehensive indicators of health. Nat. Med. 25, 1851\u20131857 (2019).","journal-title":"Nat. Med."},{"key":"3565_CR73","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"3565_CR74","doi-asserted-by":"crossref","first-page":"106373","DOI":"10.1016\/j.nbd.2023.106373","volume":"190","author":"J Timsina","year":"2024","unstructured":"Timsina, J. et al. Harmonization of CSF and imaging biomarkers in Alzheimer\u2019s disease: need and practical applications for genetics studies and preclinical classification. Neurobiol. Dis. 190, 106373 (2024).","journal-title":"Neurobiol. Dis."},{"key":"3565_CR75","volume":"15","author":"L Karlsson","year":"2024","unstructured":"Karlsson, L. et al. Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases. Nat. Commun. 15, 3676 (2024).","journal-title":"Nat. Commun."},{"key":"3565_CR76","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R. et al. Array programming with NumPy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"},{"key":"3565_CR77","doi-asserted-by":"crossref","unstructured":"McKinney, W. Data structures for statistical computing in Python. In Proc. 9th Python in Science Conference (eds van der Walt, S. & Millman, J.) 56\u201361 (SCIPY, 2010).","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"3565_CR78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"3565_CR79","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom, M. L. seaborn: statistical data visualization. J. Open Source Softw. 6, 3021 (2021).","journal-title":"J. Open Source Softw."},{"key":"3565_CR80","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods. 17, 261\u2013272 (2020).","journal-title":"Nat. Methods."},{"key":"3565_CR81","doi-asserted-by":"crossref","unstructured":"Seabold, S. & Perktold, J. Statsmodels: econometric and statistical modeling with Python. In Proc. 9th Python in Science Conference (eds van der Walt, S. & Millman, J.) 92\u201396 (SCIPY, 2010).","DOI":"10.25080\/Majora-92bf1922-011"},{"key":"3565_CR82","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"3565_CR83","doi-asserted-by":"publisher","unstructured":"Davidson-Pilon, C. Lifelines, survival analysis in Python (v0.27.0). Zenodo https:\/\/doi.org\/10.5281\/zenodo.6359609 (2022).","DOI":"10.5281\/zenodo.6359609"},{"key":"3565_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1\u201348 (2010).","journal-title":"J. Stat. Softw."},{"key":"3565_CR85","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191\u2013W198 (2019).","journal-title":"Nucleic Acids Res."},{"key":"3565_CR86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene Ontology: tool for the unification of biology. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"3565_CR87","doi-asserted-by":"crossref","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Aleksander, S. A. et al. The Gene Ontology knowledgebase in 2023. Genetics 224, iyad031 (2023).","journal-title":"Genetics"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03565-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03565-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03565-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:00:23Z","timestamp":1747738823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03565-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3565"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03565-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.22.604680","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.W-C. and H.S.-H.O. are cofounders and scientific advisers of Teal Omics and have received equity stakes. C.C. has received research support from GSK and Eisai. C.C. is a member of the scientific advisory board of Circular Genomics and owns stocks. C.C. is a member of the scientific advisory board of ADmit. C.C. and M.A. have an invention disclosure for AT\n                      1\n                      prediction models, including protein IDs, weights, cutoffs and algorithms. O.H. has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare and Roche. In the past 2 years, he has received consultancy and speaker fees from ALZpath, BioArctic, Biogen, Bristol Myers Squibb, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. H.Z. has served at scientific advisory boards or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, Cognition Therapeutics, Denali, Eisai, Labcorp, Merry Life Biomedical, NervGen Pharma, Novo Nordisk, OptoCeutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave, has given lectures in symposia sponsored by AlzeCure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk and Roche, and is a cofounder of Brain Biomarker Solutions in Gothenburg, which is a part of the GU Ventures Incubator Program (outside the submitted work). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}